| Literature DB >> 34542790 |
Shenshen Yang1, Yaqian Dong1, Yuechen Liu1, Xingxu Yan1, Guijiang Sun2, Guoxiang Jia1, Xiaokai Li1, Hui Liu1, Haihua Su3, Yubo Li4.
Abstract
Aging often leads to an increase risk of age-related diseases, and the development of anti-aging drugs have become the trend and focus of the current scientific research. In this experiment, serum samples from healthy people of different ages were analyzed based on clinical lipidomics, and a total of 10 potential biomarkers in middle-aged and youth group, 20 biomarkers in the youth and the elderly group were obtained. Furthermore, dhSph and dhCer involved above may affect the aging process through sphingolipid metabolic pathway. As the first and rate-limiting step of catalyzing de novo sphingolipid pathway, SPT may play a key role in human anti-aging, which is revealed by lipidomics liposome tracer analysis. The potential active components in ginseng on SPT was further verified by molecular docking virtual screening and atomic force microscope. Four ingredients of ginseng may reduce the levels of metabolites dhSph and dhCer by inhibiting the activity of SPT, and play an anti-aging effect by affecting the sphingolipid metabolism pathway.A clinical trials registration number: ChiCTR1900026836.Entities:
Keywords: Aging; Ginseng; Lipidomics; SPT; Sphingolipid metabolism
Mesh:
Substances:
Year: 2021 PMID: 34542790 DOI: 10.1007/s10522-021-09937-8
Source DB: PubMed Journal: Biogerontology ISSN: 1389-5729 Impact factor: 4.277